Industry Educational Session - Ask the Expert: Navigating Shared Decisions in CLL - Clinical, Moral & Cognitive Challenges- Sponsored by Lilly
Tracks
-
| Monday, April 20, 2026 |
| 5:05 PM - 5:35 PM |
| Room 4, Upper Level |
Details
This symposium has been organised and developed by Lilly for UK and Ireland HCPs only.
Explore how clinicians decide who and when to treat by weighing clinical benefit against moral and cognitive challenges, while factoring in age, performance status, comorbidities and quality of life. Examine ‘good’ shared decision making, address navigating patient preferences and complex cases, and consider how the MDT supports clear, balanced, patient centred decisions.
Speaker
Dr David Dutton
Consultant Haematologists
University Hospital Southampton
Speaker One
I am a Consultant Haematologist and honorary clinical senior lecturer working in the CLL and lymphoma team at the University of Hospitals Southampton (UHS) and University of Southampton. I am a member of the UK chronic lymphocytic leukaemia forum and focus on the biology and treatment of chronic B cell lymphoproliferative disorders.
Asjad Yousif
Lymphoma Pharmacist
Cardiff And Vale University Healthboard
Speaker Two
I am the Lymphoma/CLL pharmacist at Cardiff and Vale University Hospital. I am a non-medical prescriber who reviews, monitors and prescribes for this patient cohort. I have been working in haematology/oncology for the last 8 years.
Mrs Helen Knight
CLL Clinical Nurse Specialist
Nottingham University Hospitals
Speaker Three
I have worked within Clinical Haematology for the last 25 years on the general haematology wards and bone marrow transplant unit. For the last 12 years I have worked as the CLL Clinical Nurse Specialist at Nottingham University Hospitals. I have been able to complete the non medical prescribing course and run regular nurse led clinics every week alongside the medical team.
